SCHEMBL6748541

SCHEMBL6748541

CO[Si](OC)(OC)c1ccc(N(c2ccccc2)c2ccc(-c3ccc(N(c4ccccc4)c4ccc(C)cc4)cc3)cc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 1/20 0.36
ALDH1A1 P00352 5/20 0.36
TDP1 Q9NUW8 3/20 0.36
KDM4E B2RXH2 3/20 0.36
L3MBTL1 Q9Y468 3/20 0.36
CYP2C19 P33261 2/20 0.36
MAPT P10636 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
RAB9A P51151 3/20 0.35
HPGD P15428 2/20 0.35
NPC1 O15118 2/20 0.35
NFKB1 P19838 2/20 0.35
NFKB2 Q00653 2/20 0.35
RELA Q04206 2/20 0.35
POLB P06746 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MEN1 O00255 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6748752 1.00 APP (0.36) APPALDH1A1TDP1KDM4EL3MBTL1
SCHEMBL6750003 1.00 APP (0.36) APPALDH1A1TDP1KDM4EL3MBTL1
SCHEMBL6748645 1.00 APP (0.36) APPALDH1A1TDP1KDM4EL3MBTL1
SCHEMBL6748989 0.95 ALDH1A1 (0.39) APPALDH1A1TDP1KDM4EL3MBTL1
SCHEMBL6748388 0.95 ALDH1A1 (0.39) APPALDH1A1TDP1KDM4EL3MBTL1
SCHEMBL6746725 0.95 ALDH1A1 (0.39) APPALDH1A1TDP1KDM4EL3MBTL1
SCHEMBL6746674 0.95 ALDH1A1 (0.39) APPALDH1A1TDP1KDM4EL3MBTL1
SCHEMBL6748379 0.95 ALDH1A1 (0.39) APPALDH1A1TDP1KDM4EL3MBTL1
SCHEMBL6748565 0.93 ALDH1A1 (0.41) APPALDH1A1TDP1KDM4EL3MBTL1
SCHEMBL6748558 0.93 ALDH1A1 (0.35) ALDH1A1KDM4EMAPTRAB9AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6696588-B2 OXIDATION POTENTIAL OF .3-1.5 V ON THE BASIS OF A STANDARD HYDROGEN ELECTRODE, ALKOXY AND AROMATIC AMINE DERIVATIVES SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-02-24 US disclosed
EP-0861845-B1 Silicon-containing compound and organic electroluminescence device using the same SUMITOMO CHEMICAL CO (JP) 2003-05-28 EP disclosed
US-20020115877-A1 Silicon-containing compound and organic electroluminescence device using the same SUMITOMO CHEMICAL COMPANY, LIMITED 2002-08-22 US disclosed
US-6369258-B1 SILICON COMPOUND WITH OXIDATION POTENTIAL ON HYDROGEN ELECTRODE POTENTIAL SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2002-04-09 US disclosed
EP-0861845-A2 Silicon-containing compound and organic electroluminescence device using the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1998-09-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020115877-A1 Silicon-containing compound and organic electroluminescence device using the same EPCAM, PIEZO1, OR10J3 APP 1512/4885ALDH1A1 460/4885TDP1 4084/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.